Reply: Can pFIB scores reliably exclude significant liver fibrosis in pediatric MASLD?
Hepatology
.
2024 Aug 27.
doi: 10.1097/HEP.0000000000001069.
Online ahead of print.
Authors
Sander Lefere
1
2
,
Antonella Mosca
3
,
Christian Hudert
4
,
Ellen Dupont
5
,
Emer Fitzpatrick
6
7
,
Eirini Kyrana
8
,
Anil Dhawan
6
,
Laura Kalveram
4
,
Andrea Pietrobattista
3
,
Anja Geerts
1
2
,
Ruth De Bruyne
9
Affiliations
1
Hepatology Research Unit, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
2
Liver Research Center Ghent, Ghent University Hospital, Ghent, Belgium.
3
Hepatogastroenterology, Nutrition, Digestive Endoscopy and Liver Transplant Unit, Bambino Gesù Children's Hospital, Rome, Italy.
4
Department of Pediatric Gastroenterology, Nephrology and Metabolic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
5
Zeepreventorium, De Haan, Belgium.
6
Paediatric Liver, GI and Nutrition Centre, King's College Hospital, London, UK.
7
Department of Gastroenterology, Hepatology and Nutrition, Children's Health Ireland and University College Dublin, Dublin, Ireland.
8
Institute of Liver Studies, King's College Hospital, London, UK.
9
Department of Pediatric Gastroenterology, Hepatology and Nutrition, Ghent University, Ghent, Belgium.
PMID:
39190698
DOI:
10.1097/HEP.0000000000001069
No abstract available